Friday, April 21, 2017
Biogen's Spinraza may have raised eyebrows for its $750,000 first-year price, but the rare disease field is no stranger to expensive meds. They're pricey to develop and target few patients. Here's a list of the world's most expensive drugs, where Spinraza's annual $375,000 doesn't even break the top 10.
at 11:50:00 AM